Moreover, the effects of JOSD2 promoting LKB-WT NSCLC cells/xenografts growth in vitro/vivo depends on its enzymatic activity (Supplementary Fig. S7a–c). Here, JOSD2 is linked to non-small cell lung carcinoma.